ABUS financials
Arbutus Biopharma (ABUS) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ABUS income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $14.08M | $13.72M | -$27.05M | -$33.50M | -0.17 |
| 2024 | $6.17M | $6.17M | -$76.32M | -$69.92M | -0.38 |
| 2023 | $18.14M | $18.14M | -$78.10M | -$72.85M | -0.44 |
| 2022 | $39.02M | $39.02M | -$65.46M | -$69.46M | -0.46 |
| 2021 | $10.99M | $10.99M | -$73.52M | -$76.25M | -0.73 |
| 2020 | $6.91M | -$40.57M | -$57.81M | -$63.74M | -0.86 |
- ABUS revenue was $14.08M in fiscal 2025, net income -$33.50M.
Updated 2026-11-03 11:33 UTC